Resource Hub
Curated biotech resources
Across human-therapeutic regulators, conferences, and ecosystems: 830 links, 172 2026 conferences, 429+ organizations across 22 hubs.
Primary regulatory sources, current conference timing, and ecosystem maps - organized the way operators actually use them.
Start here
Pick your lane
Six entry points, each routed to the relevant subset of the hub.
Pre-IND prep, IND-enabling package, fundraise diligence checklist.
I'm an investor or BDDiligence checklists, conferences for partnering, regulator atlas.
I'm Reg / CMC / Clin OpsFDA + ICH + EMA + global regulators, primary-source linked.
I'm an academic or TTOSpin-out 101, SBIR primer, IP basics, university IP-licensing.
I'm outside the USPMDA, NMPA, MHRA, Health Canada, TGA, MFDS, ANVISA, CDSCO. International hubs.
Start with the glossaryPlain-language definitions for the regulator, modality, and operational terms used across the hub. 83+ entries.
Resources
Browse by category
Regulatory references, conference directories, regional ecosystem maps, and a glossary.
FAQ
Frequently asked questions
Who is this hub built for?+
Operators, investors, and partners who need primary regulatory sources, current conference timing, and ecosystem maps fast - without an aggregator paywall and without an email gate. Specifically: biotech founders, CSOs, CMOs, VPs of Regulatory and CMC, BD and Search & Evaluation leads, VC associates and principals running scientific diligence, family offices and LP diligence teams, academic PIs evaluating spin-outs, and TTOs.
Is this free? Are there hidden gates?+
Free. No registration. No email gate. Newsletter is opt-in but never required to read anything.
How do I report a missing resource, an outdated link, or a correction?+
Email tsl@bridgelinetranslational.com with the entry and the suggested change.
Is this regulatory or legal advice?+
No. All linked guidances are non-binding under 21 CFR 10.115 (FDA's regulation governing guidance documents). Documents may be superseded; consult the primary issuing source. This hub is informational. Engagement with BridgeLine is via /capabilities and /book-a-call.
The BridgeLine Brief
Strategy breakdowns, deal analysis, and drug development insights you won't find anywhere else. Written from inside the industry by someone who has built programs and evaluated companies firsthand. Plus updates when we publish new guides, tools, and resources for early-stage biotech teams.
By subscribing you agree to our Privacy Policy.
Capabilities
The four capabilities of BridgeLine Translational.
§ / Engage
Talk to BridgeLine
If the resources here are useful, the engagements behind them go deeper. Schedule a 30-minute call.